- 全部删除
 
您的购物车当前为空
Gedivumab (MHAA4549A; RG7745),一种高特异性人源单克隆抗体,靶向甲型流感病毒 (IAV),通过与IAV血凝素蛋白的高度保守茎区结合,阻止其成熟并阻断核内体中的血凝素介导的膜融合,适用于IAV感染疾病研究。
Gedivumab (MHAA4549A; RG7745),一种高特异性人源单克隆抗体,靶向甲型流感病毒 (IAV),通过与IAV血凝素蛋白的高度保守茎区结合,阻止其成熟并阻断核内体中的血凝素介导的膜融合,适用于IAV感染疾病研究。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 2,490  | 2-4周 | |
| 5 mg | ¥ 6,470  | 2-4周 | |
| 10 mg | ¥ 9,870  | 2-4周 | 
Gedivumab 相关产品
| 产品描述 | Gedivumab (MHAA4549A; RG7745), a human monoclonal antibody, exhibits high specificity in targeting the influenza A virus (IAV) by binding to the highly conserved stem region of the IAV hemagglutinin protein. This interaction inhibits hemagglutinin maturation and blocks hemagglutinin-mediated membrane fusion within the intranucleosome, making Gedivumab useful for studies on IAV infection disease [1].  | 
| CAS No. | 1807954-17-1 | 
| 存储 | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
评论内容